StockData
Davion Healthcare PLC logo

Davion Healthcare PLC (DAVI) stock

DAVINasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Last filing: 20-F on Apr 30, 2026
$1.07+0.04 (+3.88%)

Close on Nov 18, 2026Market cap –P/E –Yield –

Key statistics

Valuation at the latest close; fundamentals over fiscal

Valuation

Market cap
–
P/E ratio
–
Price to sales
–
Price to book
–
Dividend yield
–
Free cash flow yield
–

Trading

Previous close
$1.03
Open
$1.13
Day's range
$1.04 – $1.18
Volume
118,900
Average volume (20 days)
1,257,640

Press releases

Releases Davion Healthcare filed with the SEC as exhibits to Form 8-K or 6-K

All press releases and earnings

About Davion Healthcare

Surgical & Medical Instruments & Apparatus

Davion Healthcare Plc is a healthcare technology company focused on developing early-warning, non-invasive Class I medical screening devices. Its product offerings include BreastCheck, an early indicator screening test utilizing thermochromic films, and FootFlow. The company operates through a licensing and distribution commercial model, partnering with regional and global licensees such as NeuRX Health Inc. to manage manufacturing, product marketing, retail distribution, customer support, and warranty obligations. Its target end users comprise individual consumers seeking preventative wellness insights as well as healthcare providers who review test results processed via smartphone applications and proprietary artificial intelligence servers.

Company profile, executives and history

Davion Healthcare stock: common questions

What is Davion Healthcare's stock price?

DAVI closed at $1.07 on Nov 18, 2026, up 3.88% on the day.

Does Davion Healthcare pay a dividend?

No. Davion Healthcare has not paid a cash dividend over the last twelve months.

Who are Davion Healthcare's competitors?

Companies most similar to Davion Healthcare by business, industry and size include PLSM, AMIX, ODYY, INBS, FEMY.

See a number that looks wrong?